ArticleBMC pediatrics2026
Tetanus infection in an 11-year-old male with full infant vaccination history: a rare case report.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rare Survival of a 9-Year-Old Boy Managed for Post-Neonatal Tetanus Without Intensive Care at Soroti Regional Referral Hospital, Uganda: A Case Report.International medical case reports journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTetanus is a potentially life-threatening neurologic disorder caused by the toxin-producing bacterium Clostridium tetani. Primary prevention is achieved through vaccination, typically administered during infancy, however, breakthrough cases of tetanus in fully immunized individuals, especially in pediatric populations have been noted posing unique challenges for diagnosis and management. Uganda currently does not provide tetanus booster doses beyond infancy. The World Health Organisation (WHO) recommends 3 dose Tetanus Toxoid (TT) booster doses at ages 12–23 months, 4–7 years and 9–15 years whereas the US-Centers for Disease control (CDC) recommends 3 additional doses at 15–18 months, 4–6 months and at 11–12 years. This case report represents an unusual occurrence of tetanus an 11-year-old male who had completed the standard infant vaccines recommended in Uganda but still manifested with symptoms consistent with the disease. CASE PRESENTATION: An 11-year-old male Muganda was referred to Mulago National Referral Hospital's Acute Care Unit from a peripheral health facility with worsening backache, trismus, difficulty swallowing, and heightened sensitivity to touch and noise. On admission, he presented with severe pain, an arched back, and frequent muscle spasms indicative of tetanus, despite receiving the standard recommended infant vaccines in Uganda. The patient received intravenous metronidazole, alternate diazepam, and chlorpromazine, leading to a steady improvement in symptoms after which he was discharged on day 29.
conclusionThis case underscores the critical necessity of remaining vigilant for tetanus, even in individuals with a documented history of complete immunization at infancy. Additionally, this scenario highlights the pressing need for reviews of vaccination policies in regions where the recommended booster doses are not currently integrated into routine immunization schedules. Emphasizing adherence to these booster doses is key to enhancing tetanus immunity throughout childhood and adolescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.